Human epidermal growth factor receptor-2 in oesophageal cancers: an observational study.

about

Human epidermal growth factor receptor-2 in oesophageal cancers: an observational study.

Item

http://www.wikidata.org/entity/Q36429835

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Human epidermal growth factor receptor-2 in oesophageal cancers: an observational study.

@ast

Human epidermal growth factor receptor-2 in oesophageal cancers: an observational study.

@en

type

Item

label

Human epidermal growth factor receptor-2 in oesophageal cancers: an observational study.

@ast

Human epidermal growth factor receptor-2 in oesophageal cancers: an observational study.

@en

prefLabel

Human epidermal growth factor receptor-2 in oesophageal cancers: an observational study.

@ast

Human epidermal growth factor receptor-2 in oesophageal cancers: an observational study.

@en

P1476

Human epidermal growth factor receptor-2 in oesophageal cancers: an observational study

@en

P2093

Ahmed El-Hadi

http://www.w3.org/2001/XMLSchema#string

Hazem Al-Momani

http://www.w3.org/2001/XMLSchema#string

Paul Edwards

http://www.w3.org/2001/XMLSchema#string

Rachel Barnes

http://www.w3.org/2001/XMLSchema#string

Rachit Shah

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Untangling the ErbB signalling network

Coexpression of Grb7 with epidermal growth factor receptor or Her2/erbB2 in human advanced esophageal carcinoma

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

Trastuzumab--mechanism of action and use in clinical practice

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Guidelines for the management of oesophageal and gastric cancer.

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

P304

6447-51; discussion p.6450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V18.I44.6447

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wyn Lewis

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233806581

http://www.w3.org/2001/XMLSchema#string

P698

23197890

http://www.w3.org/2001/XMLSchema#string

P932

3508639

http://www.w3.org/2001/XMLSchema#string